Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$27K Sell
1,010
-100
-9% -$2.58K 0.01% 773
2014
Q3
$27K Sell
1,110
-200
-15% -$5.05K 0.01% 811
2014
Q2
$33K Buy
1,310
+160
+14% +$3.74K 0.01% 740
2014
Q1
$25K Hold
1,150
0.01% 771
2013
Q4
$26K Sell
1,150
-69
-6% -$1.52K 0.01% 739
2013
Q3
$25K Buy
1,219
+49
+4% +$1.04K 0.01% 700
2013
Q2
$23K Buy
+1,170
New +$24.4K 0.02% 638

Other funds holding HOLX

New England Securities's HOLX Position: Q4 2014 in Review

New England Securities reduced its Hologic (HOLX) stake by 9% in Q4 2014, selling an estimated $2.58K and leaving 1,010 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #773.

New England Securities first reported a position in HOLX in Q2 2013 and has held it in 7 quarters since. The position peaked at $33K in Q2 2014. 370 funds tracked by Wall St. Rank hold HOLX as of Q4 2014.

  • New England Securities held 1,010 shares of Hologic worth $27K as of Q4 2014.
  • New England Securities sold 100 Hologic shares in Q4 2014, an estimated $2.58K.
  • Hologic made up 0.01% of New England Securities's portfolio in Q4 2014, its #773 holding.
  • New England Securities first reported a position in Hologic in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Hologic position peaked at $33K in Q2 2014.
  • 370 funds tracked by Wall St. Rank held Hologic as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.